Current Oncology (Sep 2022)

Lung Metastatectomy: Can Laser-Assisted Surgery Make a Difference?

  • Konstantinos Grapatsas,
  • Anastasia Papaporfyriou,
  • Vasileios Leivaditis,
  • Benjamin Ehle,
  • Michail Galanis

DOI
https://doi.org/10.3390/curroncol29100548
Journal volume & issue
Vol. 29, no. 10
pp. 6968 – 6981

Abstract

Read online

Background: Resection of lung metastases with curative intention in selected patients is associated with prolonged survival. Laser–assisted resection of lung metastases results in complete resection of a high number of lung metastases, while preserving lung parenchyma. However, data concerning laser lung resections are scarce and contradictory. The aim of this study was to conduct a systematic review to evaluate the utility of laser-assisted pulmonary metastasectomy. Methods: An electronic search in MEDLINE (via PubMed), complemented by manual searches in article references, was conducted to identify eligible studies. Results: Fourteen studies with a total of 1196 patients were included in this metanalysis. Laser-assisted surgery (LAS) for lung metastases is a safe procedure with a postoperative morbidity up to 24.2% and almost zero mortality. LAS resulted in the resection of a high number of lung metastases with reduction of the lung parenchyma loss in comparison with conventional resection methods. Survival was similar between LAS and conventional resections. Conclusion: LAS allows radical lung-parenchyma saving resection of a high number of lung metastases with similar survival to conventional methods.

Keywords